Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

4 مناظر
administrator
administrator
07/30/23

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

  • قسم

مزید دکھائیں

کوئی تبصرہ نہیں ملا

فیس بک کے تبصرے

اگلا